SUMO1 and endometrial cancer: PGE2 can enhance proliferation and invasion of two human endometrial cancer cells (Ishikawa and HEC-1B) by stimulating EP4 receptor and small ubiquitin-like modifier-1 (SUMO-1) via the Wnt/β-catenin signaling pathway [40].